DEA

When the Drug Enforcement Administration marked its 50th anniversary last year, it had spent over $1 trillion partly to enforce Richard Nixon's 1970 Controlled Substances Act, the cornerstone of his War on Drugs, which is widely viewed as a failure. Now, doesn't this sound like the type of...

A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator Anne Milgram's authority. MedPharm, a DEA-registered research firm, criticized the exclusion of marijuana researchers and the inclusion of...

The Drug Enforcement Administration (DEA) has been barred from conducting random searches of travelers’ belongings at airports and transit hubs following a Justice Department investigation that exposed corrupt practices. The investigation, led by Inspector General Michael Horowitz, uncovered...

For the first time in years, the U.S. is witnessing a sustained decline in overdose deaths. Federal data reveals a 14.5% drop in fatalities over 12 months ending June 2024, marking a significant shift after years of grim records. Experts attribute the change to a combination of expanded harm...

Village Farms International, Inc. (NASDAQ:VFF) and Hemp for Victory filed a joint motion seeking to disqualify the Drug Enforcement Administration (DEA) from defending the proposed rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act. The parties argue that...

The Drug Enforcement Administration (DEA) may consider additional participants for its marijuana rescheduling hearings following a Nov. 15 order by chief administrative law judge (ALJ) John J. Mulrooney II. As MJBiz Daily reported, this development follows the withdrawal of some designated...

A legal dispute has erupted in Allen, Texas, where cannabis shop owners and their advocates are taking a stand against local and federal law enforcement, claiming their rights were violated during recent police raids. This lawsuit, filed by attorney David Sergi on Oct. 24, represents Sabhie Khan,...

Top Democrats from influential House committees are urging the Drug Enforcement Administration (DEA) to expedite the process of rescheduling cannabis. In a letter sent to Attorney General Merrick Garland and DEA Administrator Anne Milgram, Representatives Jerrold Nadler (D-NY) and Frank Pallone (D-...

Edwin Rubis has served 27 years of a 40-year federal prison sentence after being convicted on non-violent cannabis related charges in the late 1990s. Cannabis and criminal justice reform advocates are rallying for his release by way of a presidential pardon from the Biden Administration. Rubis, now...

Investors in the cannabis sector are closely watching the potential rescheduling of cannabis by the DEA—a decision that could reshape the industry and unlock significant tax relief. As experts at a recent webinar discussed, the path forward hinges on a key Administrative Law Judge (ALJ) hearing...

MMJ BioPharma Cultivation finds itself at the center of a pivotal legal struggle with the Drug Enforcement Administration (DEA), accusing the agency of significant delays in processing its application to grow marijuana for pharmaceutical research. The company's lawsuit claims these delays have...

One day after the September Tuesday’s presidential debate, industry experts will break down the cannabis rescheduling process, a crucial issue for investors. Equity research firm Z&A is hosting a webinar on Wednesday at 4:20 PM ET to provide insights into the upcoming regulatory shifts...

An U.S. appeals court has ruled that THC-O-acetate, a hemp-derived cannabinoid, is federally legal under the 2018 Farm Bill. This ruling contradicts the position of the Drug Enforcement Administration (DEA) on legal cannabinoids, which had classified THC-O as a Schedule I controlled...

The Mississippi State Legislature passed legislation Tuesday to establish the Mississippi Medical Cannabis Research Program at the University of Mississippi, marking a significant step forward in the study of medical marijuana applications. Governor Tate Reeves (R) ratified the bill, which aims to...

Editor’s note: this article has been updated to reflect the views of the NCR more accurately. The U.S. Drug Enforcement Administration (DEA) has scheduled a hearing on Dec. 2, 2024, to discuss the proposed reclassification of cannabis as a Schedule III substance under the Controlled...